Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Personal financial planning is vital for achieving long-term financial goals. Learn why it matters and how to get started effectively.
24,448 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
A high-profile export case links AI hardware, sanctions, and risk for investors. This article breaks down what happen...
Chewy has faced a rough year, with shares falling and growth challenges ahead. Yet, a closer look under the hood show...
In a volatile market, Hyperliquid is turning heads with its HYPE token and HIP-3 pre-IPO perps. This piece breaks dow...
A morning surge in AeroVironment stock popped today after reports of potential U.S. drone subsidies. This guide unpac...
On a day when markets slid on inflation fears, one small-cap stock surprised investors by rocketing higher. Here’s wh...
SpaceX’s IPO priced at $135 per share, raising $75 billion and signaling a landmark moment for tokenized equities as ...
As markets shift, the question isn’t just 'do I buy index funds?'—it’s 'could picking individual stocks better positi...
As Netflix eyes growth beyond original programming, could this netflix's next move involve a strategic acquisition? T...
Markets react to health headlines and policy shifts as investors reassess exposure to healthcare, insurance, and biot...
July brought a surprising bounce in the stock market as a major theater chain beat earnings expectations and drew att...
A major portfolio pivot is unfolding as 13F data reveals a famous hedge fund manager changing course. Learn why billi...